Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy
Jacqueline A. French, Roger J. Porter, Emilio Perucca, Martin J. Brodie et autres
Importance: Many patients with focal epilepsy experience seizures despite treatment with currently available antiseizure medications (ASMs) and may benefit from novel therapeutics. Objective: To evaluate the efficacy and safety of XEN1101, a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener, in the treatment …
us, au, gb, ca (code pays fourni par la source)
60 citations
JAMA Neurology